| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |